Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Allergan drug ALPHAGAN P appeared first …
New patent expiration for Allergan drug ALPHAGAN P Read Post »
Annual Drug Patent Expirations for ADVIL+PM Advil Pm is a drug marketed by Glaxosmithkline and is included in two NDAs. It is available from four suppliers. There are three patents…
The post New patent expiration for Glaxosmithkline drug ADVIL PM appea…
New patent expiration for Glaxosmithkline drug ADVIL PM Read Post »
ALPHAGAN P (brimonidine tartrate) Allergan Patent: 9,295,641 Expiration: Jan 10, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug…
Drug Patent Expirations for the Week of January 9, 2022 Read Post »
Annual Drug Patent Expirations for ALPHAGAN+P Alphagan P is a drug marketed by Allergan and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent expiration for Allergan drug ALPHAGAN P appeared first …
New patent expiration for Allergan drug ALPHAGAN P Read Post »
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twelve patents protecting this drug. This drug…
The post New patent expiration for Alnylam Pharms drug GIVLAARI appeared…
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
Annual Drug Patent Expirations for CLOBEX Clobex is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs. It is available from four suppliers.…
The post New patent expiration for Galderma Labs drug CLOBEX appeared first o…
New patent expiration for Galderma Labs drug CLOBEX Read Post »
OZEMPIC (semaglutide) Novo Patent: 9,486,588 Expiration: Jan 2, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Patent …
Drug Patent Expirations for the Week of January 2, 2022 Read Post »
Annual Drug Patent Expirations for BAQSIMI Baqsimi is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Eli Lilly drug BAQSIMI appeared first on DrugPatentWa…
New patent expiration for Eli Lilly drug BAQSIMI Read Post »
Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It is available from three suppliers. There are twenty-three patents protecting…
The post New patent expiration for NOVO drug OZEMPIC appeared fir…
Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It is available from three suppliers. There are twenty-three patents protecting…
The post New patent expiration for NOVO drug OZEMPIC appeared fir…